Macau, China

Qiong Meng


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2019-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Qiong Meng: Pioneering Glycan Biomarkers in Autoimmune Disease Research

Introduction: Qiong Meng is an innovative inventor based in Macau, China, recognized for his significant contributions to the field of autoimmune disease diagnostics. With a total of two patents to his name, Meng is at the forefront of utilizing glycan biomarkers to improve disease detection and understanding.

Latest Patents: One of Meng's latest patents focuses on the "Use of glycan as biomarkers for autoimmune diseases." This invention reveals a novel method for determining the presence of autoimmune diseases by leveraging glycan biomarkers. Additionally, it introduces an improved method for detecting trace glycans from a mixture using a microfluidic chip, enhancing detection sensitivity. This innovative approach promises to advance the technology available for diagnosing autoimmune conditions.

Career Highlights: Currently, Qiong Meng is affiliated with the Macau University of Science and Technology, where he engages in research that explores cutting-edge methods in biomedicine. His work in the university setting allows him to collaborate with top-tier researchers and contribute to academic advancements.

Collaborations: During his career, Qiong Meng has worked alongside notable colleagues, including Liang Liu and Jing-Rong Wang. Their collective efforts in research and development aim to improve understanding and treatment options for autoimmune diseases through novel biomarker applications.

Conclusion: Qiong Meng's inventive work represents a significant stride towards enhancing diagnostic methods for autoimmune diseases. His patents not only reflect his deep understanding of biomedicine but also highlight the potential for future innovations in the field. Through ongoing research and collaboration, Meng continues to pave the way for advancements that could ultimately improve patient outcomes in autoimmune disease management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…